Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones is a research paper published in Viruses (2022). On theSindex it has a DataRank of 0.596. It has been cited 52 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.596
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: U19AI171401
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: 441019/2020-0
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: 307162/2017-6
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: E-26/210.182/2020
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: E-26/201.067/2021
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: E-26/210.112/2020
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: 88887.506989/2020-00
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH)
Grant: 465313/2014-0
MeSH Terms
Keywords